• Download Fycompa-supp-featured-image
  • Posted in Supplements

  • 19th Sep 2013

  • Despite an increasing number of available treatments for epilepsy, there is a need for more effective AEDs. Perampanel, with its novel MOA, is an interesting addition to these therapeutic options and offers hope in treating uncontrolled patients. Read more about Perampanel in this  supplement to ACNR,  sponsored by Eisai. Download the full PDF by clicking the link below.

SIGN UP FOR OUR MAILING LIST

Open Access, for medical professionals: Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified. 

We may infrequently send you news from our sponsors which is relevant to the field of neurology, but you can opt out at any time.

This website is for medical professionals only.